Nurseta, Tatit, et al. “Risk of Malignancy Index 3 (RMI3) Performance As a Predictor Advanced Stage Epithelial Ovarian Carcinoma Used for NACT: Perfoma Risk of Malignancy Index 3 (RMI3) Sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut Untuk Pertimbangan Pemberian NACT”. Indonesian Journal of Obstetrics and Gynecology, vol. 10, no. 1, Jan. 2022, pp. 42-48, doi:10.32771/inajog.v10i1.1599.